Overall, taking into account the contribution of GJB2, plus the results from TRS and SNP arrays, it was possible to reach a molecular diagnosis in ~51% of NSHL cases. The gene discussed is GJB2; the disease is nodular sclerosis classical Hodgkin lymphoma.